Diabetes Associated to Atherosclerosis Risk Factors in Patients of Family Health Unity


Cardiovascular diseases, including atherosclerosis, are important causes of death among diabetics. Features of diabetes mellitus (DM) associated with atherogenic risk factors are discussed by a cross-sectional study. It was evaluated 432 families attended by Basic Family Health Unities (FHU), registered at Family Health Program (HIPERDIA) at borough Alto da Maravilha in Senhor do Bonfim, Bahia, Brazil. Among eligible patients, 50 (8.4% of the total) were included in diabetic group (DB), and 80 (9.4% of the total) in the non-diabetic group (NDB). The majority was women (90/ 130) in the age range 48 - 77. The diabetic group showed a high prevalence among analyzed variables, such as hypertension (74.0%) and obesity (46.0%). Significant differences were not found among lipoprotein cholesterol concentrations comparing the DB and NDB groups. The correlation analysis showed significant differences among LDL-C-DB and CT-DB (p < 0.0001), LDL-NDB and CT-NDB (p < 0.0001), LDL-NDB and TG-NDB (p = 0.0034), and CT-NDB and TG-NDB (p = 0.0001). Diabetic and healthy individuals do not present significant differences in the lipid profiles. By the way, the diabetic and health individuals can not present significant differences in the lipid profile, however, probably there are differences in the quality of the lipoprotein molecules between DB and NDB and a divergent tendency of the disease progression, such as a higher disposition to atherosclerosis development in DB. These patients with potential risk to development atherosclerosis or aggravation of diabetes must have more attention about Family Health Program.

Share and Cite:

Alves, P. , Santos Pereira, R. , Letti, A. and da Fonseca, Á. (2015) Diabetes Associated to Atherosclerosis Risk Factors in Patients of Family Health Unity. Open Journal of Preventive Medicine, 5, 177-185. doi: 10.4236/ojpm.2015.54021.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Navarro, S.C. and Conegero, C.I. (2002) Os fatores de risco das doenças ateroscleróticas. Arq Ciênc Saúde Unipar, 6, 151-156.
[2] DATASUS (2013) Informações de Saúde (TABNET) [Internet]. Ministério da Saúde, Brasília.
[3] Azevedo, S., Victor, E.G. and Oliveira, D.C. (2010) Diabetes mellitus e aterosclerose: Noções básicas da fisiopatologia para o clínico geral. Revista Brasileira de Clínica Médica, 8, 520-526.
[4] Beckman, J.A., Creager, M.A. and Libby, P. (2002) Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management. The Journal of the American Medical Association, 287, 2570-2581.
[5] Schaan, B.D. and Reis, A.F. (2007) Doença Cardiovascular e Diabetes. Arq Bras Endocrinol Metab, 51, 151-152.
[6] Chacra, A.R. and Alvarenga, M.A. (2008) Hiperglicemia e Doença Cardiovascular Podem Coexistir. Arq Bras Endrocrinol Metab, 52, 427-428.
[7] Santos, R.D., Giannin, S.D., Fonseca, F.H., Moriguchi, E.H., Maranhão, R.C., Luz, P.L., et al. (2001) III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arquivos Brasileiros de Cardiologia, 77, 1-48.
[8] Camacho, C.R.C., Melicio, L.A.D. and Soares, A.M.V.C. (2007) Aterosclerose, uma resposta inflamatória. Arq Ciênc Saúde, 14, 41-48.
[9] Steinberg, D. (1997) Low Density Lipoprotein Oxidation and Its Pathobiological Significance. The Journal of Biological Chemistry, 272, 20963-20966.
[10] Sociedade Brasileira de Diabetes (2003) Consenso brasileiro sobre diabetes 2002: Diagnóstico e classificação do diabetes melito e tratamento do diabetes melito do tipo 2. Diagraphic, Rio de Janeiro, 1-72.
[11] Natarajan, S., Liao, Y., Sinha, D., Cao, G., McGee, D.L. and Lipsitz, S.R. (2005) Sex Differences in the Effect of Diabetes Duration on Coronary Heart Disease Mortality. JAMA Internal Medicine, 165, 430-435.
[12] Puernell, J.Q., Hokanson, J.E., Marcovina, S.M., Steffes, M.W., Cleary, P.A. and Brunzell, J.D. (1998) Effect of Excessive Weight Gain with Intensive Therapy of Type 1 Diabetes on Lipid Levels and Blood Pressure: Results from the DCCT. The Journal of the American Medical Association, 280, 140-146.
[13] DeFronzo, R.A. (2010) Insulin Resistance, Lipotoxicity, Type 2 Diabetes and Atherosclerosis: The Missing Links. The Claude Bernard Lecture 2009. Diabetologia, 53, 1270-1287.
[14] Goldenberg, P., Schenkmans, S. and Franco, L.J. (2003) Prevalência de diabetes mellitus: Diferenças de gênero e igualdade entre os sexos. Revista Brasileira de Epidemiologia, 6, 18-28.
[15] Gross, J.L., Silveiro, S.P., Camargo, J.L., Reichelt, A.J. and Azevedo, M.J. (2002) Diabetes Melito: Diagnóstico, Classificação e Avaliação do Controle Glicêmico. Arquivos Brasileiros de Endocrinologia & Metabologia, 46, 16-26.
[16] Arora, M., Koley, S., Gupta, S. and Sandhu, J.S. (2007) A Study on Lipid Profile and Body Fat in Patients with Diabetes Mellitus. Anthropologist, 9, 295-298.
[17] Lima, E.S. and Couto, R.D. (2006) Estrutura, metabolismo e funções fisiológicas da lipoproteína de alta densidade. Jornal Brasileiro de Patologia e Medicina Laboratorial, 42, 169-178.
[18] Giuliano, I.C.B., Caramelli, B., Pellanda, L., et al. (2005) I Diretriz de Prevenção da Aterosclerose na Infancia e na Adolescência. Arquivos Brasileiros de Cardiologia, 85, 1-3.
[19] Rover, M.R.M., Kupek, E., Delgado, R.C.B. and Souza, L.C. (2010) A Importancia da Avaliação de Fatores de Risco para Aterosclerose na Infancia e Adolescência—Revisão. Newslab, 102, 136-144.
[20] Onat, A. (2011) Dynamics in Cardiometabolic Risk among Turkish Adults: Similarities to that in Iranians? International Journal of Preventive Medicine, 2, 56-63.
[21] Kawamoto, R., Oka, Y., Tomita, H. and Kodama, A. (2005) Non-HDL as a Predictor of Carotid Atherosclerosis in the Elderly. Journal of Atherosclerosis and Thrombosis, 12, 143-148.
[22] Gardener, H., Morte, D.D., Elkind, M.S.V., Sacco, R.L. and Rundek, T. (2009) Lipids and Carotid Plaque in the Northern Manhattan Study (NOMAS). BMC Cardiovascular Disorders, 9, 55.
[23] Bergmann, K. (2011) Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk. The New England Journal of Medicine, 364, 127-135.
[24] Seon, C.S., Min, K.W., Lee, S.Y., Nho, K.W., Park, S.H., Koo, B.K. and Han, K.A. (2011) Cardiovascular Risk Assessment with Vascular Function, Carotid Atherosclerosis and the UKPDS Risk Engine in Korean Patients with Newly Diagnosed Type 2 Diabetes. Diabetes and Metabolism Journal, 35, 619-627.
[25] Bianco, A., Pomara, F., Thomas, E., Paoli, A., Battaglia, G., Petrucci, M., Proia, P., Bellafiore, M. and Palma, A. (2013) Type 2 Diabetes Family Histories, Body Composition and Fasting Glucose Levels: A Cross-Section Analysis in Healthy Sedentary Male and Female. Iranian Journal of Public Health, 42, 681-690.
[26] Lotfi, M.H., Saadati, H. and Afzali, M. (2014) Prevalence of Diabetes in People Aged ≥30 Years: The Results of Screening Program of Yazd Province, Iran, in 2012. Journal of Research in Health Sciences, 14, 87-91.
[27] Maruyama, C., Imamura, K. and Teramoto, T. (2003) Assessment of LDL Particle Size by Triglyceride/HDL-Cholesterol Ratio in Non-Diabetic, Healthy Subjects without Prominent Hyperlipidemia. Journal of Atherosclerosis and Thrombosis, 10, 186-191.
[28] Vega, G.L., Barlow, C.E., Grundy, S.M., Leonard, D. and Defina, L.F. (2014) Triglyceride-to-High-Density-Lipo- protein-Cholesterol Ratio Is an Index of Heart Disease Mortality and of Incidence of Type 2 Diabetes Mellitus in Men. Journal of Investigative Medicine, 62, 345-349.
[29] Salazar, M.R., Carbajal, H.A., Espeche, W.G., Aizpurúa, M., Leiva Sisnieguez, C.E., March, C.E., Balbín, E., Stavile, R.N. and Reaven, G.M. (2013) Identifying Cardiovascular Disease Risk and Outcome: Use of the Plasma Triglyceride/ High-Density Lipoprotein Cholesterol Concentration Ratio versus Metabolic Syndrome Criteria. Journal of Internal Medicine, 273, 595-601.
[30] Vieira, E.A., Carvalho, W.A., Aras-Júnior, R., Couto, F.D. and Couto, R.D. (2011) Razão triglicérides/HDL-C e proteína C reativa de alta sensibilidade na avaliação do risco cardiovascular. Jornal Brasileiro de Patologia e Medicina Laboratorial, 47, 113-118.
[31] Solano, M.P. and Goldeberg, R.B. (2006) Lipid Management in Type 2 Diabetes. Clinical Diabetes, 24, 27-32.
[32] Khawali, C., Andriolo, A. and Ferreira, S.R.G. (2003) Benefícios da Atividade Física no perfil Lipídico de Pacientes com Diabetes Tipo 1. Arquivos Brasileiros de Endocrinologia & Metabologia, 47, 49-54.
[33] Cockerill, G.W., Rye, K.A., Gamble, J.R., Vadas, M.A. and Barter, P.J. (1995) High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 1987-1994.
[34] Barter, P.J. (2013) High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes. Endocrinology and Metabolism, 28, 169-177.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.